The Ministry of Public Health (MoPH) has added Covaxin (developed by Bharat Biotech) to the list of conditionally approved Covid-19 vaccines within its Covid-19 travel and return policy. The approval comes into immediate effect.
The other conditionally approved vaccines in Qatar are Sinopharm, Sinovac and Sputnik V. The approved vaccines are Pfizer/BioNTech (Comirnaty), Moderna (SpikeVax), AstraZeneca (Covishield/Oxford/Vaxzevria) and Jansen/Johnson & Johnson.
A serology antibody test with a positive result is mandatory before travelling to Qatar for people with two doses of a conditionally approved vaccine and 14 days after the second dose.
People who have received two doses of a conditionally approved vaccine followed by one dose of Pfizer or Moderna vaccine, and after 14 days from the last dose, will be considered fully immune.
The other conditionally approved vaccines in Qatar are Sinopharm, Sinovac and Sputnik V. The approved vaccines are Pfizer/BioNTech (Comirnaty), Moderna (SpikeVax), AstraZeneca (Covishield/Oxford/Vaxzevria) and Jansen/Johnson & Johnson.
A serology antibody test with a positive result is mandatory before travelling to Qatar for people with two doses of a conditionally approved vaccine and 14 days after the second dose.
People who have received two doses of a conditionally approved vaccine followed by one dose of Pfizer or Moderna vaccine, and after 14 days from the last dose, will be considered fully immune.